BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
PNFP
Pinnacle Financial Partners, Inc.
There isn't enough reported data to score PNFP yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PNFP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
PNFP's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like PNFP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
PNFP PE Valuation
PNFP has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over PNFP on the outlook, with more favorable profitability expectations.
PNFP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for PNFP, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
PNFP has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus PNFP up 49%.
PNFP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.30 | +44% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $7.52 | +48% |
| Q1 2025 | $6.16 | -12% |
| Q4 2024 | $5.96 | -17% |
| Q3 2024 | $5.26 | -32% |
| Q2 2024 | $5.09 | -36% |
| Q1 2024 | $6.99 | -4.1% |
| Q4 2023 | $7.18 | 0% |
PNFP earned $7.85 per share over the past year, up 49% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
PNFP has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 160% for PNFP.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
PNFP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +141% |
| Q2 2026 | $1.2B | +138% |
| Q1 2026 | $1.2B | +163% |
| Q3 2025 | $544.8M | +17% |
| Q2 2025 | $505M | +38% |
| Q1 2025 | $462.9M | +8.1% |
| Q4 2024 | $475.3M | +20% |
| Q3 2024 | $466.7M | +14% |
PNFP's revenue has grown year over year for eight quarters in a row: $1.3B last quarter, up 160% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -2.1 points |
| Q2 2026 | 35% | -3.6 points |
| Q1 2026 | 16% | -21 points |
| Q3 2025 | 39% | -0.3 points |
| Q2 2025 | 38% | +21 points |
| Q1 2025 | 37% | +1.5 points |
| Q4 2024 | 39% | +6.1 points |
| Q3 2024 | 39% | -2.4 points |
PNFP has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
PNFP has the stronger cash trend. Its trailing FCF is up 167% versus its history, compared with BAC at up 119%.
PNFP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $365M | -2.8% |
| Q2 2026 | $67M | -73% |
| Q1 2026 | $911M | +$954M |
| Q3 2025 | $375.4M | +291% |
| Q2 2025 | $244.6M | +316% |
| Q1 2025 | -$43M | -124% |
| Q4 2024 | $475M | +423% |
| Q3 2024 | $96M | -9.9% |
PNFP's free cash flow was $1.7B over the past year, up 122% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PNFP.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over PNFP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
PNFP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +250K shares |
| 1 year | +96% | +74.4M shares |
| 3 years | +99% | +75.6M shares |
| 5 years | +100% | +75.9M shares |
| Available history | +98% | +75M shares |
PNFP has 152M diluted shares, up 96% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $50.8M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PNFP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.9x | Moderate |
| Q3 2024 | 3.8x | Elevated |
| Q2 2024 | 4.0x | High |
| Q1 2024 | 3.2x | Elevated |
| Q4 2023 | 3.1x | Elevated |
PNFP's net debt is about 2.2 years of its operating earnings (EBITDA), down from 3.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PNFP.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PNFP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 49.9 | Neutral |
PNFP's weekly RSI is 51 (neutral) and its Stochastic is 50 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
PNFP PE vs Financial Services Sector
| Metric | PNFP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PNFP has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PNFP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.7 | 1.6% above |
| 20 week MA | $100.2 | 0.9% below |
| 50 week MA | $97.2 | 2.2% above |
| 100 week MA | $100.0 | 0.7% below |
| 200 week MA | $89.3 | 11% above |
PNFP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
PNFP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.8 | $65.3 | +2.3% |
| 2021 | $65.3 | $93.9 | +44% |
| 2022 | $93.9 | $73.6 | -22% |
| 2023 | $73.6 | $87.2 | +19% |
| 2024 | $87.2 | $114.2 | +31% |
| 2025 | $114.2 | $100.8 | -12% |
| 2026 YTD | $100.8 | $99.3 | -1.5% |
PNFP has the edge over BAC on returns for 2026, with the stronger performance.